{"id":24482,"date":"2019-11-25T10:00:28","date_gmt":"2019-11-25T09:00:28","guid":{"rendered":"https:\/\/www.icscyl.com\/mileon\/?p=24482"},"modified":"2019-11-24T18:58:58","modified_gmt":"2019-11-24T17:58:58","slug":"sesion-bibliografica-nejm-canakinumab-y-colchicina-en-la-prevencion-de-eventos-coronarios","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/sesiones-bibliograficas\/2019-11-25\/sesion-bibliografica-nejm-canakinumab-y-colchicina-en-la-prevencion-de-eventos-coronarios\/","title":{"rendered":"Sesi\u00f3n bibliogr\u00e1fica NEJM: Canakinumab y colchicina en la prevenci\u00f3n de eventos coronarios"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignright is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pbs.twimg.com\/profile_images\/893483773362393088\/US3DliFV_400x400.jpg\" alt=\"Resultado de imagen de nejm\" width=\"158\" height=\"158\"\/><\/figure><\/div>\n\n\n\n<p>La sesi\u00f3n bibliogr\u00e1fica del pasado viernes fue presentada por el Dr. Quiroga, que repas\u00f3 los siguientes art\u00edculos publicados en New England Journal Medicine:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Canakinumab therapy for atheroesclerotic disease<\/li><li>Low-dose methotrexate for the prevention of atheroesclerotic events<\/li><li>Efficacy and safety of low-dose colchicine after myocardial infarction<\/li><li>Catheter ablation for atrial fibrillation with heart failure<\/li><li>Nintedanib in progressive fibrosing intersticial lung diseases<\/li><\/ul>\n\n\n\n<p>Al t\u00e9rmino de la sesi\u00f3n se produjo un breve debate sobre la distinta aplicabilidad\/eficacia de estos f\u00e1rmacos (canakinumab y colchicina) en la prevenci\u00f3n de eventos coronarios. En esta ocasi\u00f3n la sesi\u00f3n est\u00e1 dividida en dos archivos por la imposibilidad de reducirla.<\/p>\n\n\n\n<div class=\"wp-block-file\"><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2019\/11\/Dr-Quiroga-sesbibl-Nov19-1.pdf\">Dr-Quiroga-sesbibl-Nov19-1<\/a><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2019\/11\/Dr-Quiroga-sesbibl-Nov19-1.pdf\" class=\"wp-block-file__button\" download>Descarga<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2019\/11\/Dr-Quiroga-sesbibl-Nov19-2.pdf\">Dr-Quiroga-sesbibl-Nov19-2<\/a><a href=\"https:\/\/www.icscyl.com\/mileon\/wp-content\/uploads\/2019\/11\/Dr-Quiroga-sesbibl-Nov19-2.pdf\" class=\"wp-block-file__button\" download>Descarga<\/a><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La sesi\u00f3n bibliogr\u00e1fica del pasado viernes fue presentada por el Dr. Quiroga, que repas\u00f3 los siguientes art\u00edculos publicados en New England Journal Medicine: Canakinumab therapy for atheroesclerotic disease Low-dose methotrexate for the prevention of atheroesclerotic events Efficacy and safety of low-dose colchicine after myocardial infarction Catheter ablation for atrial fibrillation with heart failure Nintedanib in [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[722],"tags":[983],"class_list":["post-24482","post","type-post","status-publish","format-standard","hentry","category-sesiones-bibliograficas","tag-quiroga"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/24482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=24482"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/24482\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=24482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=24482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=24482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}